Custom Health Aims to Become Publicly Traded Company through Business Combination with Queue Ventures
Custom Health is excited to announce that it has entered into a definitive agreement to complete a business combination with Queue Ventures Ltd. This transaction marks a significant step forward in Custom Health’s mission to scale its innovative, technology-enabled healthcare model across North America.
The agreement positions Custom Health to become a publicly listed company on the Toronto Stock Exchange (TSX), unlocking access to growth capital that will accelerate the expansion of its personalized care platform. By integrating smart medication packaging, in-home technology, and real-time clinical oversight, Custom Health supports patients with chronic conditions in staying healthy at home.
In connection with the transaction, Custom Health and Queue have engaged Stifel Nicolaus Canada Inc. to lead a private placement of up to US$30 million and a debt financing of up to US$30 million.
Read the full announcement here: Newsfile Release